ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BENNETT | — |
| AMY DEMSKE | — |
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Health Issues HCR
Food and Drug Administration policy on chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES RAVITZ | — |
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.